Myelin is an evolutionarily novel and important structure for the proper functioning of the vertebrate nervous system.
In the central nervous system (CNS), the myelin sheath is elaborated by oligodendrocytes, and is composed of development. In this special issue, He and Lu [1] first provide a comprehensive overview of the molecular regulation of oligodendrocyte specification and differentiation by both genetic and epigenetic mechanisms. Huang et al. [2] further discuss the timing control of oligodendrocyte differentiation during development and the possible underlying mechanisms. The next two papers [3, 4] describe a special type of oligodendrocyte progenitor, the NG2-positive polydendrocyte, and provide strong evidence for its active participation in myelin repair following demyelinating lesions.
Oligodendrocyte differentiation is accompanied by the formation of compact myelin sheaths around axons.
Axonal myelination is a complicated, coordinated biological process. In this issue, Dr. Macklin provides a thorough review of both positive and negative regulators of CNS myelination, and presents additional original data on the negative regulation of axonal myelination [5] . Mei et al. [6] discuss the interesting and important topic of how the numbers and lengths of myelin internodes formed by oligodendrocytes are controlled at the molecular level.
Once myelin is formed, there are extensive and intimate interactions between axons and oligodendrocyte processes. Bankston et al. [7] describe how neurons are supported by oligodendrocytes via diverse molecular and cellular mechanisms including metabolic and neurotrophic support, and suggest that oligodendrocyte pathology may [8] provide an in-depth review of the pathophysiology of MS, current treatments, and potential strategies for the development of drug candidates that directly target remyelination and neuroprotection. Also, Cao and He discuss the response and polarization of microglia and macrophages in MS, and their effects on its pathogenesis and repair [9] . Furthermore, Liu et al. [10] consider another form of demyelinating disease, periventricular leukomalacia, which is characterized by selective whitematter myelin damage in premature infants and is the leading cause of cerebral palsy in these infants. In adult animals, demyelination can be selectively induced in the corpus callosum by cuprizone, and this demyelination can cause deficits in exploratory behavior. Interestingly, the vulnerability of myelin to this chemical appears to be agedependent [11] .
In summary, the articles presented in this special issue cover a wide spectrum of oligodendrocyte biology and pathology. We hope that this special issue will further stimulate interest in the further identification and characterization of regulatory molecules involved in normal myelination, and more importantly, in developing novel molecular and cellular approaches to facilitating myelin repair in demyelinating diseases and in spinal cord/brain injury.
